EcoDrugPlus

Glutaminase

Ensembl ID : ENSOCUG00000002448
Gene Symbol: GLS
2 Cross references
302 Possible Orthologues:

Glycogen Synthase Kinase 3 Alpha

Ensembl ID : ENSOCUG00000006441
Gene Symbol: GSK3A
2 Cross references
260 Possible Orthologues:

Glycogen Synthase Kinase 3 Beta

Ensembl ID : ENSOCUG00000014932
Gene Symbol: GSK3B
3 Cross references
241 Possible Orthologues:

Gonadotropin Releasing Hormone Receptor

Ensembl ID : ENSOCUG00000016998
Gene Symbol: GNRHR
3 Cross references
454 Possible Orthologues:

Guanylate Cyclase 1 Soluble Subunit Alpha 1

Ensembl ID : ENSOCUG00000004455
Gene Symbol: GUCY1A1
2 Cross references
202 Possible Orthologues:

Guanylate Cyclase 1 Soluble Subunit Alpha 2

Ensembl ID : ENSOCUG00000004490
Gene Symbol: GUCY1A2
2 Cross references
201 Possible Orthologues:

Guanylate Cyclase 1 Soluble Subunit Beta 1

Ensembl ID : ENSOCUG00000001814
Gene Symbol: GUCY1B1
3 Cross references
209 Possible Orthologues:

Heat Shock Protein 90 Alpha Family Class A Member 1

Ensembl ID : ENSOCUG00000001280
Gene Symbol: HSP90AA1
2 Cross references
204 Possible Orthologues:

Histamine Receptor H2

Ensembl ID : ENSOCUG00000011627
Gene Symbol: HRH2
3 Cross references
249 Possible Orthologues:

Histamine Receptor H4

Ensembl ID : ENSOCUG00000001327
Gene Symbol: HRH4
3 Cross references
105 Possible Orthologues:

Histone Deacetylase 1

Ensembl ID : ENSOCUG00000003674
Gene Symbol: HDAC1
3 Cross references
284 Possible Orthologues:

Histone Deacetylase 10

Ensembl ID : ENSOCUG00000025188
Gene Symbol: HDAC10
2 Cross references
181 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).